These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
    Author: Reinhardt MJ, Müller-Mattheis VG, Gerharz CD, Vosberg HR, Ackermann R, Müller-Gärtner HW.
    Journal: J Nucl Med; 1997 Jan; 38(1):99-101. PubMed ID: 8998160.
    Abstract:
    We describe a patient whose primary tumor was a testicular teratocarcinoma predominantly composed of embryonal carcinoma. Before chemotherapy, the retroperitoneal metastases demonstrated heterogeneous, increased glucose metabolism as measured by 2-[18F]fluoro-2-deoxy-D-glucose and PET (FDG-PET). After chemotherapy, FDG uptake was reduced to normal values despite increased tumor volume. Histology revealed a pure mature teratoma. This observation suggests that further studies are needed to determine whether tumor differentiation of testicular teratocarcinoma metastases can be assessed by measuring glucose metabolism.
    [Abstract] [Full Text] [Related] [New Search]